Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
ClinicalTrials.gov study NCT03836261. IPD Sharing: Not stated. Countries: 27. Publications: 4.
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
ClinicalTrials.gov study NCT00546793. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients
ClinicalTrials.gov study NCT02345863. IPD Sharing: NO. Countries: 1. Publications: 3.
Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients with Relapsed/refractory CLL
ClinicalTrials.gov study NCT03787264. IPD Sharing: NO. Countries: 1. Publications: 3.
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
ClinicalTrials.gov study NCT00812669. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
ClinicalTrials.gov study NCT00457860. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04809467. IPD Sharing: YES. Countries: 7. Publications: 0.
Pneumococcal Vaccine in Untreated CLL Patients
ClinicalTrials.gov study NCT01892618. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
ClinicalTrials.gov study NCT02194387. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I/II Study of GX15-070MS in Untreated CLL
ClinicalTrials.gov study NCT00600964. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig
ClinicalTrials.gov study NCT03730129. IPD Sharing: NO. Countries: 1. Publications: 19.
Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL
ClinicalTrials.gov study NCT02758665. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting
ClinicalTrials.gov study NCT03342144. IPD Sharing: UNDECIDED. Countries: 3. Publications: 1.
Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG)
ClinicalTrials.gov study NCT02401503. IPD Sharing: NO. Countries: 1. Publications: 3.
Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL
ClinicalTrials.gov study NCT04862806. IPD Sharing: NO. Countries: 1. Publications: 1.
Registry of the German CLL Study Group
ClinicalTrials.gov study NCT02863692. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT03331198. IPD Sharing: UNDECIDED. Countries: 2. Publications: 3.
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
ClinicalTrials.gov study NCT02580552. IPD Sharing: NO. Countries: 1. Publications: 12.
Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)
ClinicalTrials.gov study NCT02689141. IPD Sharing: NO. Countries: 1. Publications: 3.
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
ClinicalTrials.gov study NCT00709033. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.